systematic review radiation therapy trials prostate cancer performed according principles adopted swedish council technology assessment health care sbu synthesis literature based data NUMBER randomized trials dealing hormonal therapy NUMBER prospective trials NUMBER retrospective studies totally studies included NUMBER patients lack properly controlled clinical trials important aspects radiation therapy prostate cancer conclusions reached summarized follows randomized studies compare outcome surgery radical prostatectomy external beam radiotherapy brachytherapy patients clinically localized prostate cancer advent widely accepted prognostic markers prostate cancer psa gleason score comparisons possible substantial documentation large series patients disease category psa NUMBER gs NUMBER t2b showing outcome external beam radiotherapy brachytherapy similar surgery fairly strong evidence patients localized intermediate risk high risk psa NUMBER gs NUMBER t2 disease patients normally suited surgery benefit higher conventional total dose overall survival benefit shown dose escalation patients disease performed 3d conformal radiotherapy photon proton boost high dose rate brachytherapy boost brachytherapy boost permanent seed implantation despite increased risk urinary tract rectal effects therapy generally safely delivered techniques evidence 3d conformal radiotherapy results reduced late rectal toxicity acute anal toxicity compared radiotherapy administered treatment volumes evidence postoperative external beam radiotherapy radical prostatectomy patients pt3 disease prolongs biochemical survival likelihood achieving dfs higher treatment given adjuvant salvage setting breakpoint exist psa level NUMBER likelihood eradication recurrence cancer diminishes prostatectomy endocrine therapy prior adjuvant radiotherapy result longer biochemical survival adjuvant radiotherapy given impact overall survival shown fairly strong evidence endocrine therapy prior radiotherapy results increased survival increased local control reduced incidence distant metastases reduced mortality patients locally advanced disease evidence endocrine therapy prior radiotherapy results increased overall survival subset gs patients locally advanced disease strong evidence adjuvant endocrine treatment curative radiotherapy results improved local control increased freedom distant metastases increased survival patients advanced disease moderately strong evidence adjuvant endocrine treatment radiotherapy results longer overall survival compared radiotherapy patients advanced disease references NUMBER meta analysis low risk pre treatment t stage single institutional multi institutional pre treatment intermediate risk high risk ir NUMBER dose escalated non conformal disease free long term disease free short term disease free cause specific short term NUMBER NUMBER disease free loco regionally high risk loco regionally ng ml